The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

Patients either got a weekly 2.4 milligram dose of semaglutide, the active ingredient in Ozempic and Wegovy, or a placebo, for 72 weeks. The trial found that about 63% of patients in the ...

Starting this week, Hims & Hers said its members may be prescribed Wegovy, starting at $599 per month through NovoCare Pharmacy. In early March, Novo Nordisk had said it would sell all dose ...

The Danish company has submitted the NDA to seek FDA approval for a once-daily 25 mg dose oral version of Wegovy for chronic weight management in obese and overweight adults who indicate at least ...